Is BNGO a buy right now?

Is BNGO a buy right now?

Those tracked by the Wall Street Journal have BNGO rated as a consensus « buy » with an average $12 price target.

Similarly, What kind of stock is BNGO?

Key Data

Label Value
Sector Capital Goods
Industry Biotechnology: Laboratory Analytical Instruments
1 Year Target $10.00
Today’s High/Low $2.18/$2.07

How much does BNGO cost? Predicted Opening Price for BioNano Genomics Inc. of Thursday, March 24, 2022

Fair opening price March 24, 2022 Current price
$2.40 $2.40 (Undervalued)

Thereof, How do I buy stocks in BNGO?

How to Buy BNGO Stock

  1. Pick a brokerage. Retail investors like yourself are buying stocks through the brokers. …
  2. Decide how many shares you want. After you open and fund your brokerage account you’re ready to buy the shares. …
  3. Choose your order type. …
  4. Execute your trade.

Is BNGO a buy Zacks?

See rankings and related performance below. The VGM Score are a complementary set of indicators to use alongside the Zacks Rank.

Momentum Scorecard. More Info.

Zacks Rank Definition Annualized Return
1 Strong Buy 24.93%
2 Buy 18.44%
3 Hold 9.99%
4 Sell 5.61%

What is BNGO target price?

The 4 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 7.50, with a high estimate of 14.00 and a low estimate of 6.00. The median estimate represents a +258.85% increase from the last price of 2.09.

Is BNGO a pump and dump?

BNGO stock has suffered at the hands of a Ritalin-using pump and dump scheme making waves in 2021.

What does BNGO company do?

Company Description

The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics.

What does Bionano Genomics do?

Bionano Genomics, Inc. provides a platform to analyze the long segments of genomic DNA and other biomolecules structural variations. The Company offers proprietary nanochannel chips, automated imaging instrument, integrated primary and secondary software, and application specific reagents.

Who owns Bionano genomics?

Top 10 Owners of Bionano Genomics Inc

Stockholder Stake Shares owned
BlackRock Fund Advisors 5.74% 16,609,007
The Vanguard Group, Inc. 4.86% 14,064,639
SSgA Funds Management, Inc. 2.49% 7,198,880
Geode Capital Management LLC 1.63% 4,714,883

How high does IDEX go?

IDEX stock hit a 2022 high of $1.44 in early January and a low of $0.87 later in the same month. In 2021 its stock price ranged from 88 cents to $5.53. In an interview with Capital.com, Vinod Jain, senior analyst at Aite-Novarica Group, said “the stock could see more volatility due to its current price point”.

Is BNGO a meme stock?

Admittedly, it has been a while since Bionano Genomics (NASDAQ:BNGO) stock has been a “hot stock,” a “meme stock” or whatever you want to call it. Since its big drop in late February and early March, the market has had mixed feelings about this life sciences company.

Will BNGO get FDA approval?

The Food and Drug Administration has not yet approved the device for use as a medical diagnostic tool in the U.S. However, healthcare entities can still use it for research purposes. The lack of FDA approval has also not hindered sales of the Saphyr in other countries.

Where is BNGO based?

The company was founded in 2003 and is headquartered in San Diego, California.

Is BNGO an American company?

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. … The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.

How does BioNano genomics make money?

Revenue is produced by either directly selling the data to outsiders or by leveraging it for internal reasons, such as increasing the efficacy of advertising.

How many employees does BNGO have?

Compare BNGO With Other Stocks

Bionano Genomics Annual Number of Employees
2020 147
2019 97
2018 77
2017 65

What institutions are buying NIO?

Largest shareholders include Baillie Gifford & Co, BlackRock Inc., Vanguard Group Inc, State Street Corp, VWIGX – Vanguard International Growth Fund Investor Shares, Susquehanna International Group, Llp, Goldman Sachs Group Inc, Citadel Advisors Llc, VEIEX – Vanguard Emerging Markets Stock Index Fund Investor Shares, …

What institutions are buying BNGO?

Bionano Genomics (NASDAQ:BNGO) Institutional Buying and Selling

Reporting Date Hedge Fund Ownership in Company
2/14/2022 Nuveen Asset Management LLC 0.357%
2/14/2022 Barclays PLC 0.123%
2/14/2022 GSA Capital Partners LLP 0.019%
2/14/2022 Mutual Advisors LLC 0.017%

Is Ideanomics a Chinese company?

IDEX Stock and the Chinese EV Business

But it’s important to remember what Ideanomics’ Chinese EV business is at the moment. It’s a reseller. It buys vehicles in bulk and sells them individually, earning a spread in the process.

Is IDEX undervalued?

PB vs Industry: IEX is overvalued based on its PB Ratio (5.3x) compared to the US Machinery industry average (2.4x).

Is it good to buy IDEX stock?

Is IDEX a Good Stock to Buy? In my judgment, IDEX is a good stock to buy at current prices. It is relatively cheap compared to other EV car companies such as Nio and Tesla. In addition, it is racking up strategic partnerships along the way, making it a competitive player in a post-fossil-fuel-driven world.

Does Ark hold BNGO?

Ark Invest’s Chapter in the BNGO Stock Story

The fund manager has sent some public praise BNGO’s way. Ark even has a special portfolio — Ark Genomic Revolution ETF (NYSEARCA:ARKG) — for just that sort of stock material.

Why does Bionano have tremendous potential?

The Bottom Line on BNGO Stock

Saphyr allows diseases to be more effectively researched than competing products. And, it is tremendously cheaper than other genomic-mapping tools. But it could also more successfully determine patients more susceptible to severe cases of viruses. These viruses include Covid-19.

What is a Bionano chip?

Built using proprietary Nanochannel technology, Bionano Chips for the Saphyr® and Irys® systems linearize DNA, enabling high-speed, high-throughput optical genome mapping and structural variation detection for a variety of applications including human and clinical research.

Join TheMoney.co community and don’t forget to share this post !

Quitter la version mobile